The latest news and updates from Cancer Cytopathology
View in a web browser | View in a mobile device

Wiley Logo  
 
Cancer Cytopathology
 
Dear Colleague,

Happy 2015!

As always, we’re excited to offer an unprecedented wealth of practical, cutting-edge content to our valued readership. Our goal is to maintain a high-quality output, while continually enhancing our impact and reputation among the field. Here’s a taste of the excitement currently surrounding Cancer Cytopathology:

Cancer Cytopathology’s growth has included the now-monthly publication of CytoSource, our free news and views section edited by Dr. Terence Colgan. In the January 2015 issue, we unveil a fresh, inviting new layout. We hope readers will enjoy the vibrant look of CytoSource’s timely, topical content.

Two new sections are thriving, and continue to grow:

Clinician’s Corner (edited by Dr. Martha Bishop Pitman) focuses on the specific management of cytologic diagnoses. Dr. Carlos Fernandez-del Castillo, pancreatic surgeon from the Massachusetts General Hospital, highlighted the need for and value of standardized terminology for pancreaticobiliary cytology in our June 2014 issue.

Cytopathology Help Desk (edited by Dr. Gladwyn Leiman) continues to explore insights and answers to controversies in cytopathology. Leigh Ann Cahill, senior cytotechnologist at Virginia Commonwealth University, detailed the evolution of cervical cancer screening and its implications for cytotechnologists in our July 2014 issue.

Clinician’s Corner   Cytopathology Help Desk
 
Celebrating early-career cytopathologists

We’re seeking candidates for our new 2015 Young Investigator Challenge: a call for papers from early-career cytopathologists who want to showcase their work in Cancer Cytopathology. The winner will have their work published, and will be given special recognition by the journal and editors. We encourage those working with any potential candidates to help us identify up-and-coming talent. Stay tuned for more details!
 
Keeping up to date with Cancer Cytopathology

Don’t forget – there are a number of ways to stay up-to-date with us. One of our most popular CytoSource articles asked the question, “Should pathology get more social?” Well, we can certainly say that Cancer Cytopathology has become more social! We’re very proud of the fantastic social media growth we’ve had over the last year, in which we more than doubled our Twitter following. You can follow us (@CancerCytopath) for our latest content, as well as timely tweets from Associate Editor Dr. Martha Bishop Pitman.
         
twitter   facebook   google plus

And iPad users can find all of our content on our sleek new app!
 
Cancer Cytopathology / Download the official iPad app here
 
Top-cited cytopathology articles

Congratulations to Shahreen Billah MD, John Stewart MD, Gregg Staerkel MD, Su Chen MD, Yun Gong MD, and Ming Guo MD from MD Anderson Cancer Center for having the top-cited article last year, entitled “EGFR and KRAS mutations in lung carcinoma.” This study examined the utility and confirmed the reliability of routine cytology specimens in molecular testing, specifically in the detection of EGFR and KRAS mutations in patients with non-small cell lung cancer.
 
More reasons to submit

After analyzing our competitors' submission and publication data for all of 2013, we were pleased to note that Cancer Cytopathology delivered the fastest time to publication (an average of just 16 weeks!).

graph
 
Our 2014 time to publication fell even further, and now stands at less than 13 weeks, on average. This alone is a great reason to submit, but we're also immensely proud to boast:

bullet An outstanding 2013 Impact Factor of 3.807 – far and away the highest in the discipline
bullet The quickest and most comprehensive peer review process in the field
bullet Never any submission or illustration charges
 
Editorial board news

2015 also ushers in the second term of our revised Editorial Board. I want to thank our board for its diligent work in allowing us to realize several strategic goals, positioning Cancer Cytopathology as the strongest, most trusted journal in cytopathology. This year’s new additions include:

Guoping Cai   Brian Collins   Yun Gong   Adele Kraft   Mauro Saieg
                 
Guoping Cai, MD
Yale School of Medicine
  Brian Collins, MD
Washington University School of Medicine
  Yun Gong, MD
Anderson Cancer Center
  Adele Kraft, MD
Virginia Commonwealth University
  Mauro Saieg, MD, PhD – Santa Casa Medical School, São Paulo, Brazil
 
We encourage input from our readership. Please contact any of our editors with ideas and questions you may want us to address. We can always be reached at cancercyto@cancer.org. The Associate Editors and I will work diligently not only to publish cutting edge research in cytopathology, but to anticipate your needs as readers as you advance your cytopathology practice.

Sincerely,



Celeste N. Powers, MD, PhD
Editor-in-Chief, Cancer Cytopathology
Celeste N. Powers, MD, PhD


  Copyright © John Wiley & Sons, Inc. or related companies. All rights reserved. Wiley Logo